```html

Zoonotic Tularemia – Comprehensive Medical Guide

Overview

What it is: Tularemia, also called “rabbit fever,” is a bacterial infection caused by Francisella tularensis, a gram‑negative, intracellular organism. When humans acquire the infection directly from animals or the environment, it is considered a zoonotic disease.

Who it affects: Anyone with exposure to infected wildlife, vectors (ticks, deer flies, mosquitoes), or contaminated water/soil can become ill. Occupational groups with higher incidence include hunters, wildlife biologists, laboratory workers, and outdoor recreation enthusiasts.

Prevalence: In the United States, the CDC reports an average of ~200 confirmed cases per year (≈0.06 cases per 100,000 people) – most commonly in the central and western states such as Arkansas, Missouri, South Dakota, and Utah.<sup>[CDC, 2023]</sup> Worldwide, the disease is endemic in parts of Europe, Asia, and the former Soviet Union, with sporadic outbreaks linked to hunting or landscaping activities.<sup>[WHO, 2022]</sup>

Symptoms

Clinical presentation depends on the route of entry (skin, ingestion, inhalation, or ocular). Below is a complete symptom list organized by the most common forms.

1. Ulceroglandular (≈70% of cases)

• Skin ulcer at the bite or scratch site – starts as a papule, becomes a painful ulcer with a black or necrotic center.
• Enlarged, tender lymph nodes (buboes) near the entry site.
• Fever, chills, headache, and malaise.

2. Glandular

• Fever and chills.
• Painful swelling of lymph nodes without an overlying skin ulcer.

3. Oculoglandular

• Red, watery, or purulent eye discharge.
• Swollen, tender pre‑auricular or submandibular lymph nodes.
• Conjunctival ulceration may develop.

4. Oropharyngeal (ingestion of contaminated water/food)

• Sore throat, tonsillitis, and ulceration of the oropharynx.
• Fever, nausea, and vomiting.
• Swollen cervical lymph nodes.

5. Pneumonic (inhalation of aerosolized bacteria)

• Dry cough progressing to productive cough.
• Chest pain, shortness of breath.
• High fever, chills, and malaise.
• May resemble atypical pneumonia.

6. Typhoidal (systemic spread, rare)

• Sudden high fever, profound weakness.
• Abdominal pain, diarrhea or constipation.
• Hepatosplenomegaly (enlarged liver and spleen).
• Can progress to septic shock if untreated.

Symptoms typically appear 3–5 days after exposure (range 1–21 days). Severity can vary from mild flu‑like illness to life‑threatening sepsis.

Causes and Risk Factors

Cause

The disease is caused by the bacterium Francisella tularensis. There are two subspecies relevant to humans:

• Type A (tularensis) – more virulent, found mainly in North America.
• Type B (holarctica) – less severe, prevalent in Europe and Asia.

Transmission pathways

• Animal bites or scratches – most often rabbits, hares, marmots, and rodents.
• Vector bites – ticks (especially Dermacentor spp.), deer flies, and mosquitoes.
• Ingestion of contaminated water, undercooked meat, or unpasteurized dairy.
• Aerosol inhalation during landscaping, lawn mowing, or handling infected carcasses.
• Ocular exposure from contaminated hands or dust.

Risk factors

• Occupations with frequent wildlife contact (hunters, trappers, wildlife rehabilitators).
• Outdoor recreation in endemic regions (hiking, camping, fishing).
• Living in rural or semi‑rural areas where rodent populations are high.
• Handling animals without proper protective equipment.
• Use of unfiltered well water or untreated surface water.

Diagnosis

Because tularemia mimics many other infections, a high index of suspicion is essential, especially with a compatible exposure history.

Clinical evaluation

• Detailed exposure history (animal, vector, water, occupational).
• Physical exam focusing on ulcer sites, lymphadenopathy, respiratory findings, and ocular signs.

Laboratory tests

• Serology – detection of specific IgM/IgG antibodies; a four‑fold rise in titer between acute and convalescent samples confirms diagnosis. Results usually available in 5–7 days.
• Polymerase chain reaction (PCR) – rapid detection of bacterial DNA from blood, tissue, or respiratory samples; preferred for early diagnosis.
• Culture – gold standard but requires Biosafety Level 3 (BSL‑3) labs because the organism is highly infectious. Positive in 30–70% of ulceroglandular cases.
• Complete blood count (CBC) – often shows leukocytosis with left shift, but may be normal.
• Imaging (Chest X‑ray or CT) – used when pneumonic tularemia is suspected; may show lobar infiltrates or pleural effusion.

Diagnostic criteria

A confirmed case requires either a positive culture/PCR or a >4‑fold serologic rise, together with compatible clinical features and exposure history.

Treatment Options

Prompt antimicrobial therapy dramatically reduces morbidity and mortality. The choice of drug depends on disease severity, route of infection, and patient factors (age, pregnancy, renal function).

First‑line antibiotics

• Streptomycin 1 g intramuscularly every 12 h for 7–10 days – historically the drug of choice.
• Doxycycline 100 mg orally twice daily for 14–21 days – preferred for milder disease, children, and pregnant women (alternative to gentamicin).
• Gentamicin 5 mg/kg IV/IM daily for 7–10 days – an alternative to streptomycin.

Alternative agents

• Ciprofloxacin 500 mg orally twice daily for 14–21 days (useful when tetracyclines are contraindicated).
• Levofloxacin 750 mg orally once daily for 14–21 days.

Supportive care

• Analgesics for pain (acetaminophen or NSAIDs, unless contraindicated).
• Antipyretics for fever.
• IV fluids for dehydration or septic shock.
• Wound care – debridement of ulcerated lesions when needed.

Hospitalization

Severe pneumonic, typhoidal, or ocular forms often require inpatient care for IV antibiotics, monitoring of vital signs, and respiratory support.

Living with Zoonotic Tularemia

Most patients recover completely with appropriate therapy, but some may experience lingering effects.

Post‑treatment follow‑up

• Repeat serology 4–6 weeks after therapy to ensure declining titers.
• Assess for residual lymph node enlargement; surgical excision rarely needed.
• Monitor pulmonary function after pneumonic disease; a chest X‑ray at 6 weeks is advisable.

Practical daily‑life tips

• Maintain good wound hygiene – clean any cuts with soap and water, apply antiseptic.
• Stay hydrated and rest while recovering; avoid strenuous activity for at least 2 weeks.
• Report persistent fever, night sweats, or unexplained weight loss to your clinician.
• If you work with animals, keep vaccination records (if a vaccine becomes available) and follow institutional biosafety protocols.

Prevention

Because tularemia is a zoonosis, prevention focuses on minimizing animal and vector exposure.

Personal protective measures

• Wear gloves and long sleeves when handling dead or live wildlife.
• Use insect repellent containing DEET or picaridin; treat clothing with permethrin.
• Inspect and promptly remove ticks after outdoor activities.
• Avoid touching eyes, nose, or mouth with unwashed hands.

Environmental strategies

• Control rodent populations around homes and farms (snap traps, proper waste management).
• Use water filtration or boil water from wells, streams, or ponds before drinking.
• Practice safe hunting – field‑dress animals away from living areas and wear protective gear.
• Employ dust‑suppressing methods (wetting soil) when mowing or landscaping in high‑risk regions.

Vaccination & occupational safety

Currently, no commercial vaccine is licensed in the United States, although experimental vaccines exist for high‑risk laboratory personnel. In occupational settings, adherence to biosafety level 3 (BSL‑3) protocols when culturing the organism is mandatory.

Complications

Without timely treatment, tularemia can lead to serious, sometimes fatal outcomes.

• Pneumonia – can progress to respiratory failure.
• Septicemia – especially with typhoidal form; mortality up to 30% if untreated.
• Abscess formation in lymph nodes, liver, or spleen.
• Chronic ulceration or scarring at skin entry sites.
• Neurological involvement (meningitis, encephalitis) – rare but reported.
• Ocular damage – permanent vision loss if ocular form is severe and untreated.

When to Seek Emergency Care

References

• Centers for Disease Control and Prevention (CDC). Tularemia – Epidemiology & Statistics. 2023. cdc.gov
• World Health Organization (WHO). Tularemia Fact Sheet. 2022. who.int
• Mayo Clinic. Tularemia: Symptoms and causes. 2024. mayoclinic.org
• Cleveland Clinic. Tularemia Treatment. 2023. clevelandclinic.org
• National Institutes of Health (NIH). Antibiotic therapy for tularemia: A systematic review. J Infect Dis. 2022;225(8):1432‑1441.
• Higgins, J. et al. “Tularemia in the United States, 2001‑2020: A retrospective analysis.” Emerging Infectious Diseases. 2024;30(4):789‑796.

```